← All trials
NCT04948554
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 16, 2021
- Primary completion
- Dec 31, 2027
- Completion date
- May 31, 2028
- First posted
- Jul 2, 2021
- Last posted
- Nov 17, 2021
- Enrollment
- 210
- Arms / groups
- 9 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Acceleron Pharma, Inc.Lead sponsor
- Acceleron Pharma, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.